2025-01-17 - LD Munich - Sanofi v. Accord Healthcare et al. - UPC_CFI_145/2024; UPC_CFI_146/2024; UPC_CFI_147/202; UPC_CFI_148/2024

Aktenzeichen:
UPC_CFI_145/2024; UPC_CFI_146/2024; UPC_CFI_147/202; UPC_CFI_148/2024
Datum:
Spruchkörper:
Court of First Instance - Munich (DE) Local Division
Art:
Order
Parteien:
Sanofi v. Accord / Stada / Reddy / Zentiva

Kernaussage: 1.

2025-01-17 - LD Munich - Sanofi v. Accord Healthcare et al. - UPC_CFI_145/2024; UPC_CFI_146/2024; UPC_CFI_147/202; UPC_CFI_148/2024
🏛️Court of First Instance - Munich (DE) Local Division• Order
📅2025-01-17
🔢UPC_CFI_145/2024; UPC_CFI_146/2024; UPC_CFI_147/202; UPC_CFI_148/2024
Parteien & Vertreter
UPC_CFI_145/2024
Kläger / Berufungsführer
Sanofi Mature IP
Sanofi Winthrop Industrie
Sanofi-Aventis GmbH
Sanofi Belgium
Sanofi-Aventis Deutschland GmbH
Sanofi S.r.l.
Sanofi B.V.
Sanofi - Produtos Farmaceuticos Lda
Sanofi AB
Sanofi A/S
Frédéric CHEVALLIER
Beklagter / Berufungsbeklagter
Accord Healthcare S.L.U.
Accord Healthcare GmbH
Accord Healthcare BV
Accord Healthcare Italia Srl
Accord Healthcare B.V.
Accord Healthcare, Unipessoal Lda.
Accord Healthcare AB
Jules FABRE
UPC_CFI_146/2024
Kläger / Berufungsführer
Sanofi Mature IP
Sanofi Winthrop Industrie
Sanofi-Aventis France
Sanofi-Aventis GmbH
Sanofi Belgium
Sanofi-Aventis Deutschland GmbH
Sanofi S.r.l.
Sanofi B.V.
Sanofi - Produtos Farmaceuticos Lda
Sanofi AB
Sanofi A/S
Agathe MICHEL-DE CAZOTTE
Beklagter / Berufungsbeklagter
STADAPHARM GmbH
STADA Arzneimittel AG
STADA Nordic ApS
Konstantin SCHALLMOSER
UPC_CFI_148/2024
Kläger / Berufungsführer
Sanofi Mature IP
Sanofi Winthrop Industrie
Sanofi-Aventis France
Sanofi-Aventis GmbH
Sanofi Belgium
Sanofi-Aventis Deutschland GmbH
Sanofi S.r.l.
Sanofi B.V.
Sanofi - Produtos Farmaceuticos Lda
Sanofi AB
Sanofi A/S
Agathe MICHEL-DE CAZOTTE
Beklagter / Berufungsbeklagter
Zentiva France
Zentiva Pharma GmbH
Zentiva, k.s.
Anja LUNZE
📋ORD_2029/2025
⚖️Application Rop305
🌐English

1. Sanofi Mature IP is to be substituted by Sanofi SA in the present action and all related proceedings. 2. Claimant No. 1 shall be designated “Sanofi SA as successor of Sanofi Mature IP “. 3. This replacement of parties has no consequence on the proceedings within the meaning of Rules 306 and 310 RoP. Sanofi SA as successor of Sanofi Mature IP is bound by the proceedings as now constituted.

The Munich Local Division issued this order relating to four different litigations with the same claimant, substituting one of the claimants who had become the patent's new proprietor. The Court stated that due to the succession a substitution was admissible.
Stichwörter
change in parties, Rule 305 RoP

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren